Top

Diabetologia

Published in:

01-11-2010 | Article

Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus

Authors: P. L. Yau, D. C. Javier, C. M. Ryan, W. H. Tsui, B. A. Ardekani, S. Ten, A. Convit

Published in: Diabetologia | Issue 11/2010

Abstract

Aims/hypothesis

Central nervous system abnormalities, including cognitive and brain impairments, have been documented in adults with type 2 diabetes who also have multiple co-morbid disorders that could contribute to these observations. Assessing adolescents with type 2 diabetes will allow the evaluation of whether diabetes per se may adversely affect brain function and structure years before clinically significant vascular disease develops.

Methods

Eighteen obese adolescents with type 2 diabetes and 18 obese controls without evidence of marked insulin resistance, matched on age, sex, school grade, ethnicity, socioeconomic status, body mass index and waist circumference, completed MRI and neuropsychological evaluations.

Results

Adolescents with type 2 diabetes performed consistently worse in all cognitive domains assessed, with the difference reaching statistical significance for estimated intellectual functioning, verbal memory and psychomotor efficiency. There were statistical trends for executive function, reading and spelling. MRI-based automated brain structural analyses revealed both reduced white matter volume and enlarged cerebrospinal fluid space in the whole brain and the frontal lobe in particular, but there was no obvious grey matter volume reduction. In addition, assessments using diffusion tensor imaging revealed reduced white and grey matter microstructural integrity.

Conclusions/interpretation

This is the first report documenting possible brain abnormalities among obese adolescents with type 2 diabetes relative to obese adolescent controls. These abnormalities are not likely to result from education or socioeconomic bias and may result from a combination of subtle vascular changes, glucose and lipid metabolism abnormalities and subtle differences in adiposity in the absence of clinically significant vascular disease. Future efforts are needed to elucidate the underlying pathophysiological mechanisms.

Hannon TS, Rao G, Arslanian SA (2005) Childhood obesity and type 2 diabetes mellitus. Pediatrics 116:473–480CrossRefPubMed

Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333–1346CrossRefPubMed

Awad N, Gagnon M, Messier C (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26:1044–1080CrossRefPubMed

Manschot SM, Brands AMA, van der Grond J et al (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106–1113CrossRefPubMed

Pirttila T, Jarvenpaa R, Laippala P, Frey H (1992) Brain atrophy on computerized axial tomography scans: interaction of age, diabetes and general morbidity. Gerontology 38:285–291CrossRefPubMed

Araki Y, Nomura M, Tanaka H et al (1994) MRI of the brain in diabetes mellitus. Neuroradiology 36:101–103CrossRefPubMed

van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diab Care 29:2539–2548CrossRef

van Harten B, Oosterman J, Muslimovic D, van Loon B-JP, Scheltens P, Weinstein HC (2007) Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36:164–170CrossRefPubMed

Gold S, Dziobek I, Sweat V et al (2007) Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50:711–719CrossRefPubMed

10.

den Heijer T, Vermeer SE, van Dijk EJ et al (2003) Type 2 diabetes and atrophy of the medial temporal lobe structures on brain MRI. Diabetologia 46:1604–1610CrossRef

11.

Northam EA, Rankins D, Lin A et al (2009) Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diab Care 32:445–450CrossRef

12.

Perantie DC, Wu J, Koller JM et al (2007) Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diab Care 30:2331–2337CrossRef

13.

Eppens MC, Craig ME, Cusumano J et al (2006) Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diab Care 29:1300–1306CrossRef

14.

Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM (2009) Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation 119:2913–2919CrossRefPubMed

15.

Heilman K, Zilmer M, Zilmer K et al (2009) Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. Diabetes Res Clin Pract 84:168–173CrossRefPubMed

16.

Mabbott DJ, Noseworthy M, Bouffet E, Laughlin S, Rockel C (2006) White matter growth as a mechanism of cognitive development in children. Neuroimage 33:936–946CrossRefPubMed

17.

Grieve SM, Williams LM, Paul RH, Clark CR, Gordon E (2007) Cognitive aging, executive function, and fractional anisotropy: A diffusion tensor MR imaging study. AJNR Am J Neuroradiol 28:226–235PubMed

18.

Dayyat E, Kheirandish-Gozal L, Sans Capdevila O, Maarafeya MMA, Gozal D (2009) Obstructive sleep apnea in children: Relative contributions of body mass index and adenotonsillar hypertrophy. Chest 136:137–144CrossRefPubMed

19.

Gozal D, Kheirandish-Gozal L (2007) Neurocognitive and behavioral morbidity in children with sleep disorders. Curr Opin Pulm Med 13:505–509CrossRefPubMed

20.

Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, Harper RM (2008) Brain structural changes in obstructive sleep apnea. Sleep 31:967–977PubMed

21.

Mather KJ, Hunt AE, Steinberg HO et al (2001) Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metab 86:5457–5464CrossRefPubMed

22.

Radziuk J (2004) Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426–4433CrossRef

23.

Expert Panel (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef

24.

Mindell J, Owens J (2003) A clinical guide to pediatric sleep: diagnosis and management of sleep problems. Lippincott Williams & Wilkins, Philadelphia

25.

Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment. Oxford University Press, New York

26.

Scheltens P, Barkhof F, Leys D et al (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114:7–12CrossRefPubMed

27.

Basser PJ, Pierpaoli C (1996) Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111:209–219CrossRefPubMed

28.

Irwan R, Sijens PE, Potze JH, Oudkerk M (2005) Correlation of proton MR spectroscopy and diffusion tensor imaging. Magn Reson Imaging 23:851–858CrossRefPubMed

29.

Good CD, Johnsrude IS, Ashburner J, Henson RNA, Friston KJ, Frackowiak RSJ (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36CrossRefPubMed

30.

Giedd JN, Blumenthal J, Jeffries NO et al (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2:861–863CrossRefPubMed

31.

Convit A, Wolf OT, de Leon MJ et al (2001) Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res 107:61–73CrossRefPubMed

32.

Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H (1995) A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 19:615–623CrossRefPubMed

33.

Yau PL, Javier D, Tsui WH et al (2009) Emotional and neutral declarative memory impariments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res 174:223–230CrossRefPubMed

34.

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300

35.

Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A (2001) Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull 54:255–266CrossRefPubMed

36.

Smith KJ, Kapoor R, Felts PA (2009) Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 9:62–92

37.

Veglio F, Paglieri C, Rabbia F, Bisbocci D, Bergui M, Cerrato P (2009) Hypertension and cerebrovascular damage. Atherosclerosis 205:331–341CrossRefPubMed

38.

Novak V, Last D, Alsop DC et al (2006) Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diab Care 29:1529–1534CrossRef

39.

Benton D, Parker PY, Donohoe RT (1996) The supply of glucose to the brain and cognitive functioning. J Biol Sci 28:463–479

40.

Drake CT, Iadecola C (2007) The role of neuronal signaling in controlling cerebral blood flow. Brain Lang 102:141–152CrossRefPubMed

41.

Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI (1996) Impaired peripheral vasomotion in diabetes. Diab Care 19:715–721CrossRef

42.

Tooke JE, Hannemann MM (2000) Adverse endothelial function and the insulin resistance syndrome. J Intern Med 247:425–431CrossRefPubMed

43.

Manschot S, Biessels G, de Valk H et al (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50:2388–2397CrossRefPubMed

44.

Hagberg H, Mallard C (2005) Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18:117–123CrossRefPubMed

45.

Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG (2006) Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296:421–426CrossRefPubMed

46.

Bruehl H, Sweat V, Hassenstab J, Polyakov V, Convit A (2010) Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol 32:487–493CrossRefPubMed

Title: Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus
Authors: P. L. Yau
D. C. Javier
C. M. Ryan
W. H. Tsui
B. A. Ardekani
S. Ten
A. Convit
Publication date: 01-11-2010
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 11/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1857-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 11/2010

In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study

Expression analysis of loci associated with type 2 diabetes in human tissues

Multidrug therapy in a patient with Rabson–Mendenhall syndrome

A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

Ageing brain abnormalities in young obese patients with type 2 diabetes: a cause for concern

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials